Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion type Assertion NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_head.
- NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_provenance.
- NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion evidence source_evidence_literature NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_provenance.
- NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion SIO_000772 3179449 NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_provenance.
- NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion wasDerivedFrom befree-2016 NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_provenance.
- NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_assertion wasGeneratedBy ECO_0000203 NP1300617.RAPv1UI8TadsFiQh0lg7bxg2LvQed3Pob5LYr6SEVit0w130_provenance.